Global Pet Arthritis Market Research Report 2024

Publication ID:

PB504251657

Publication Date:

April 16, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The increasing companion animal population, growing prevalence of arthritis, rising risk factors for the disease, supportive awareness programs initiated by governments, and strategies implemented by key companies are some of the key factors driving the market.
The global Pet Arthritis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 39%.
This report aims to provide a comprehensive presentation of the global market for Pet Arthritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Arthritis.
Report Scope
The Pet Arthritis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Arthritis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Arthritis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Virbac
Elanco
Boehringer Ingelheim International GmbH
Ceva
Dechra Pharmaceuticals PLC.
Vetoquinol
NexGen Pharmaceuticals
Norbrook
Eltech K-Laser s.r.l.
Segment by Type
Osteoarthritis
Other Arthritis
Segment by Application
Dogs
Cats
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Arthritis companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Arthritis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Osteoarthritis
1.2.3 Other Arthritis
1.3 Market by Application
1.3.1 Global Pet Arthritis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Arthritis Market Perspective (2019-2030)
2.2 Pet Arthritis Growth Trends by Region
2.2.1 Global Pet Arthritis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pet Arthritis Historic Market Size by Region (2019-2024)
2.2.3 Pet Arthritis Forecasted Market Size by Region (2025-2030)
2.3 Pet Arthritis Market Dynamics
2.3.1 Pet Arthritis Industry Trends
2.3.2 Pet Arthritis Market Drivers
2.3.3 Pet Arthritis Market Challenges
2.3.4 Pet Arthritis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Arthritis Players by Revenue
3.1.1 Global Top Pet Arthritis Players by Revenue (2019-2024)
3.1.2 Global Pet Arthritis Revenue Market Share by Players (2019-2024)
3.2 Global Pet Arthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Arthritis Revenue
3.4 Global Pet Arthritis Market Concentration Ratio
3.4.1 Global Pet Arthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Arthritis Revenue in 2023
3.5 Pet Arthritis Key Players Head office and Area Served
3.6 Key Players Pet Arthritis Product Solution and Service
3.7 Date of Enter into Pet Arthritis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Arthritis Breakdown Data by Type
4.1 Global Pet Arthritis Historic Market Size by Type (2019-2024)
4.2 Global Pet Arthritis Forecasted Market Size by Type (2025-2030)
5 Pet Arthritis Breakdown Data by Application
5.1 Global Pet Arthritis Historic Market Size by Application (2019-2024)
5.2 Global Pet Arthritis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pet Arthritis Market Size (2019-2030)
6.2 North America Pet Arthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pet Arthritis Market Size by Country (2019-2024)
6.4 North America Pet Arthritis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Arthritis Market Size (2019-2030)
7.2 Europe Pet Arthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pet Arthritis Market Size by Country (2019-2024)
7.4 Europe Pet Arthritis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Arthritis Market Size (2019-2030)
8.2 Asia-Pacific Pet Arthritis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pet Arthritis Market Size by Region (2019-2024)
8.4 Asia-Pacific Pet Arthritis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Arthritis Market Size (2019-2030)
9.2 Latin America Pet Arthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pet Arthritis Market Size by Country (2019-2024)
9.4 Latin America Pet Arthritis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Arthritis Market Size (2019-2030)
10.2 Middle East & Africa Pet Arthritis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pet Arthritis Market Size by Country (2019-2024)
10.4 Middle East & Africa Pet Arthritis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Pet Arthritis Introduction
11.1.4 Zoetis Revenue in Pet Arthritis Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Virbac
11.2.1 Virbac Company Detail
11.2.2 Virbac Business Overview
11.2.3 Virbac Pet Arthritis Introduction
11.2.4 Virbac Revenue in Pet Arthritis Business (2019-2024)
11.2.5 Virbac Recent Development
11.3 Elanco
11.3.1 Elanco Company Detail
11.3.2 Elanco Business Overview
11.3.3 Elanco Pet Arthritis Introduction
11.3.4 Elanco Revenue in Pet Arthritis Business (2019-2024)
11.3.5 Elanco Recent Development
11.4 Boehringer Ingelheim International GmbH
11.4.1 Boehringer Ingelheim International GmbH Company Detail
11.4.2 Boehringer Ingelheim International GmbH Business Overview
11.4.3 Boehringer Ingelheim International GmbH Pet Arthritis Introduction
11.4.4 Boehringer Ingelheim International GmbH Revenue in Pet Arthritis Business (2019-2024)
11.4.5 Boehringer Ingelheim International GmbH Recent Development
11.5 Ceva
11.5.1 Ceva Company Detail
11.5.2 Ceva Business Overview
11.5.3 Ceva Pet Arthritis Introduction
11.5.4 Ceva Revenue in Pet Arthritis Business (2019-2024)
11.5.5 Ceva Recent Development
11.6 Dechra Pharmaceuticals PLC.
11.6.1 Dechra Pharmaceuticals PLC. Company Detail
11.6.2 Dechra Pharmaceuticals PLC. Business Overview
11.6.3 Dechra Pharmaceuticals PLC. Pet Arthritis Introduction
11.6.4 Dechra Pharmaceuticals PLC. Revenue in Pet Arthritis Business (2019-2024)
11.6.5 Dechra Pharmaceuticals PLC. Recent Development
11.7 Vetoquinol
11.7.1 Vetoquinol Company Detail
11.7.2 Vetoquinol Business Overview
11.7.3 Vetoquinol Pet Arthritis Introduction
11.7.4 Vetoquinol Revenue in Pet Arthritis Business (2019-2024)
11.7.5 Vetoquinol Recent Development
11.8 NexGen Pharmaceuticals
11.8.1 NexGen Pharmaceuticals Company Detail
11.8.2 NexGen Pharmaceuticals Business Overview
11.8.3 NexGen Pharmaceuticals Pet Arthritis Introduction
11.8.4 NexGen Pharmaceuticals Revenue in Pet Arthritis Business (2019-2024)
11.8.5 NexGen Pharmaceuticals Recent Development
11.9 Norbrook
11.9.1 Norbrook Company Detail
11.9.2 Norbrook Business Overview
11.9.3 Norbrook Pet Arthritis Introduction
11.9.4 Norbrook Revenue in Pet Arthritis Business (2019-2024)
11.9.5 Norbrook Recent Development
11.10 Eltech K-Laser s.r.l.
11.10.1 Eltech K-Laser s.r.l. Company Detail
11.10.2 Eltech K-Laser s.r.l. Business Overview
11.10.3 Eltech K-Laser s.r.l. Pet Arthritis Introduction
11.10.4 Eltech K-Laser s.r.l. Revenue in Pet Arthritis Business (2019-2024)
11.10.5 Eltech K-Laser s.r.l. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Zoetis
Virbac
Elanco
Boehringer Ingelheim International GmbH
Ceva
Dechra Pharmaceuticals PLC.
Vetoquinol
NexGen Pharmaceuticals
Norbrook
Eltech K-Laser s.r.l.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂